ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes

Recruiting Observational Study
Attention Deficit Hyerpactivity Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 – 17
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
King's College London · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental condition affecting 5.9% of young people. Late adolescence can be a particularly challenging period for young people with ADHD, with major life transitions, new demands and increased expectations. This vulnerable phase also coincides with the transition from child and adolescent mental health care to adult ADHD services…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of DSM-5 ADHD * Aged 16-17 * Able to give informed consent for participation * Willing and able to complete self-reported assessments via smartphone * Willing to use either their own compatible Android phone or a study Android - phone as their only smartphone during …
Contacts

Aislinn Bowler, PhD

07503926683

art-transition@kcl.ac.uk

CONTACT